Phathom Pharmaceuticals to Present at 20th Annual Needham Virtual Healthcare Conference
FLORHAM PARK, N.J., April 06, 2021 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, announced today that members of the management team will participate in a fireside chat at the 20th Annual Needham Virtual Healthcare Conference on Tuesday, April 13, 2021 at 10:15 a.m. ET.
Company management will also participate in one-on-one meetings during the virtual conference which runs from April 12-15, 2021.
To access the live webcast and archived recording of the presentation, visit the News & Events section of the Phathom website at . The recording will be available for 90 days following the event.
About Phathom
Phathom Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of novel treatments for gastrointestinal diseases and disorders. Phathom has in-licensed the exclusive rights in the United States, Europe, and Canada to vonoprazan, a novel potassium competitive acid blocker (P-CAB) in late-stage development for the treatment of acid-related disorders. For more information about Phathom, visit the Company’s website at or follow the Company on social media: LinkedIn at and Twitter .
CONTACTS
Media Contact:
Nick Benedetto
1-877-742-8466
Investor Contact:
Todd Branning
1-877-742-8466
